世界のインフルエンザワクチン接種市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Influenza Vaccination Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3167 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、インフルエンザワクチン接種のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（卵ベース、細胞培養、組換え）、用途別市場規模（病院、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・インフルエンザワクチン接種の市場動向 ・企業の競争状況、市場シェア ・インフルエンザワクチン接種の種類別市場規模（卵ベース、細胞培養、組換え） ・インフルエンザワクチン接種の用途別市場規模（病院、研究機関） ・インフルエンザワクチン接種の北米市場規模2016-2027（アメリカ、カナダ） ・インフルエンザワクチン接種のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・インフルエンザワクチン接種のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・インフルエンザワクチン接種の中南米市場規模2016-2027（メキシコ、ブラジル） ・インフルエンザワクチン接種の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott (U.S.)、AstraZeneca (Europe)、BioCryst Pharmaceuticals, Inc. (U.S.)、Novartis AG (Europe)、DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)、GlaxoSmithKline plc. (Europe)、Hualan Biological Engineering Inc (Asia Pacific)、Mitsubishi Tanabe Pharma Corporation (Asia Pacific)、F. Hoffmann-La Roche Ltd (Europe)、Sanofi (Europe)） ・結論

Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

Market Analysis and Insights: Global Influenza Vaccination Market
The global Influenza Vaccination market size is projected to reach US$ 4872.9 million by 2026, from US$ 3501.6 million in 2019, at a CAGR of 4.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Vaccination market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Vaccination market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Vaccination market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Vaccination market.

Global Influenza Vaccination Scope and Market Size
Influenza Vaccination market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Egg Based
Cell Culture
Recombinant

Segment by Application
Hospitals
Research Organizations

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals, Inc. (U.S.)
Novartis AG (Europe)
DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
GlaxoSmithKline plc. (Europe)
Hualan Biological Engineering Inc (Asia Pacific)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
F. Hoffmann-La Roche Ltd (Europe)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Egg Based
1.2.3 Cell Culture
1.2.4 Recombinant
1.3 Market by Application
1.3.1 Global Influenza Vaccination Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Research Organizations
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Influenza Vaccination Market Perspective (2016-2027)
2.2 Influenza Vaccination Growth Trends by Regions
2.2.1 Influenza Vaccination Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Vaccination Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Vaccination Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Vaccination Industry Dynamic
2.3.1 Influenza Vaccination Market Trends
2.3.2 Influenza Vaccination Market Drivers
2.3.3 Influenza Vaccination Market Challenges
2.3.4 Influenza Vaccination Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Influenza Vaccination Players by Revenue
3.1.1 Global Top Influenza Vaccination Players by Revenue (2016-2021)
3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Vaccination Revenue
3.4 Global Influenza Vaccination Market Concentration Ratio
3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2020
3.5 Influenza Vaccination Key Players Head office and Area Served
3.6 Key Players Influenza Vaccination Product Solution and Service
3.7 Date of Enter into Influenza Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Vaccination Breakdown Data by Type
4.1 Global Influenza Vaccination Historic Market Size by Type (2016-2021)
4.2 Global Influenza Vaccination Forecasted Market Size by Type (2022-2027)

5 Influenza Vaccination Breakdown Data by Application
5.1 Global Influenza Vaccination Historic Market Size by Application (2016-2021)
5.2 Global Influenza Vaccination Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Influenza Vaccination Market Size (2016-2027)
6.2 North America Influenza Vaccination Market Size by Type
6.2.1 North America Influenza Vaccination Market Size by Type (2016-2021)
6.2.2 North America Influenza Vaccination Market Size by Type (2022-2027)
6.2.3 North America Influenza Vaccination Market Size by Type (2016-2027)
6.3 North America Influenza Vaccination Market Size by Application
6.3.1 North America Influenza Vaccination Market Size by Application (2016-2021)
6.3.2 North America Influenza Vaccination Market Size by Application (2022-2027)
6.3.3 North America Influenza Vaccination Market Size by Application (2016-2027)
6.4 North America Influenza Vaccination Market Size by Country
6.4.1 North America Influenza Vaccination Market Size by Country (2016-2021)
6.4.2 North America Influenza Vaccination Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Influenza Vaccination Market Size (2016-2027)
7.2 Europe Influenza Vaccination Market Size by Type
7.2.1 Europe Influenza Vaccination Market Size by Type (2016-2021)
7.2.2 Europe Influenza Vaccination Market Size by Type (2022-2027)
7.2.3 Europe Influenza Vaccination Market Size by Type (2016-2027)
7.3 Europe Influenza Vaccination Market Size by Application
7.3.1 Europe Influenza Vaccination Market Size by Application (2016-2021)
7.3.2 Europe Influenza Vaccination Market Size by Application (2022-2027)
7.3.3 Europe Influenza Vaccination Market Size by Application (2016-2027)
7.4 Europe Influenza Vaccination Market Size by Country
7.4.1 Europe Influenza Vaccination Market Size by Country (2016-2021)
7.4.2 Europe Influenza Vaccination Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccination Market Size (2016-2027)
8.2 Asia-Pacific Influenza Vaccination Market Size by Type
8.2.1 Asia-Pacific Influenza Vaccination Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Vaccination Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Vaccination Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Vaccination Market Size by Application
8.3.1 Asia-Pacific Influenza Vaccination Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Vaccination Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Vaccination Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Vaccination Market Size by Region
8.4.1 Asia-Pacific Influenza Vaccination Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Vaccination Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Influenza Vaccination Market Size (2016-2027)
9.2 Latin America Influenza Vaccination Market Size by Type
9.2.1 Latin America Influenza Vaccination Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Vaccination Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Vaccination Market Size by Type (2016-2027)
9.3 Latin America Influenza Vaccination Market Size by Application
9.3.1 Latin America Influenza Vaccination Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Vaccination Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Vaccination Market Size by Application (2016-2027)
9.4 Latin America Influenza Vaccination Market Size by Country
9.4.1 Latin America Influenza Vaccination Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Vaccination Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Influenza Vaccination Market Size (2016-2027)
10.2 Middle East & Africa Influenza Vaccination Market Size by Type
10.2.1 Middle East & Africa Influenza Vaccination Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Vaccination Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Vaccination Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Vaccination Market Size by Application
10.3.1 Middle East & Africa Influenza Vaccination Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Vaccination Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Vaccination Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Vaccination Market Size by Country
10.4.1 Middle East & Africa Influenza Vaccination Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Vaccination Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Details
11.1.2 Abbott (U.S.) Business Overview
11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2016-2021)
11.1.5 Abbott (U.S.) Recent Development
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Details
11.2.2 AstraZeneca (Europe) Business Overview
11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2016-2021)
11.2.5 AstraZeneca (Europe) Recent Development
11.3 BioCryst Pharmaceuticals, Inc. (U.S.)
11.3.1 BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
11.3.2 BioCryst Pharmaceuticals, Inc. (U.S.) Business Overview
11.3.3 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Introduction
11.3.4 BioCryst Pharmaceuticals, Inc. (U.S.) Revenue in Influenza Vaccination Business (2016-2021)
11.3.5 BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
11.4 Novartis AG (Europe)
11.4.1 Novartis AG (Europe) Company Details
11.4.2 Novartis AG (Europe) Business Overview
11.4.3 Novartis AG (Europe) Influenza Vaccination Introduction
11.4.4 Novartis AG (Europe) Revenue in Influenza Vaccination Business (2016-2021)
11.4.5 Novartis AG (Europe) Recent Development
11.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
11.5.2 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Business Overview
11.5.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Introduction
11.5.4 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021)
11.5.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
11.6 GlaxoSmithKline plc. (Europe)
11.6.1 GlaxoSmithKline plc. (Europe) Company Details
11.6.2 GlaxoSmithKline plc. (Europe) Business Overview
11.6.3 GlaxoSmithKline plc. (Europe) Influenza Vaccination Introduction
11.6.4 GlaxoSmithKline plc. (Europe) Revenue in Influenza Vaccination Business (2016-2021)
11.6.5 GlaxoSmithKline plc. (Europe) Recent Development
11.7 Hualan Biological Engineering Inc (Asia Pacific)
11.7.1 Hualan Biological Engineering Inc (Asia Pacific) Company Details
11.7.2 Hualan Biological Engineering Inc (Asia Pacific) Business Overview
11.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Introduction
11.7.4 Hualan Biological Engineering Inc (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021)
11.7.5 Hualan Biological Engineering Inc (Asia Pacific) Recent Development
11.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
11.8.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Business Overview
11.8.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Introduction
11.8.4 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021)
11.8.5 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
11.9 F. Hoffmann-La Roche Ltd (Europe)
11.9.1 F. Hoffmann-La Roche Ltd (Europe) Company Details
11.9.2 F. Hoffmann-La Roche Ltd (Europe) Business Overview
11.9.3 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Introduction
11.9.4 F. Hoffmann-La Roche Ltd (Europe) Revenue in Influenza Vaccination Business (2016-2021)
11.9.5 F. Hoffmann-La Roche Ltd (Europe) Recent Development
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Details
11.10.2 Sanofi (Europe) Business Overview
11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2016-2021)
11.10.5 Sanofi (Europe) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Influenza Vaccination Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Egg Based
Table 3. Key Players of Cell Culture
Table 4. Key Players of Recombinant
Table 5. Global Influenza Vaccination Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Influenza Vaccination Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Influenza Vaccination Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Influenza Vaccination Market Share by Regions (2016-2021)
Table 9. Global Influenza Vaccination Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Influenza Vaccination Market Share by Regions (2022-2027)
Table 11. Influenza Vaccination Market Trends
Table 12. Influenza Vaccination Market Drivers
Table 13. Influenza Vaccination Market Challenges
Table 14. Influenza Vaccination Market Restraints
Table 15. Global Influenza Vaccination Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Influenza Vaccination Market Share by Players (2016-2021)
Table 17. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccination as of 2020)
Table 18. Ranking of Global Top Influenza Vaccination Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Influenza Vaccination Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Influenza Vaccination Product Solution and Service
Table 22. Date of Enter into Influenza Vaccination Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Influenza Vaccination Revenue Market Share by Type (2016-2021)
Table 26. Global Influenza Vaccination Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Influenza Vaccination Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Influenza Vaccination Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Influenza Vaccination Revenue Market Share by Application (2016-2021)
Table 30. Global Influenza Vaccination Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Influenza Vaccination Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Influenza Vaccination Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Influenza Vaccination Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott (U.S.) Company Details
Table 63. Abbott (U.S.) Business Overview
Table 64. Abbott (U.S.) Influenza Vaccination Product
Table 65. Abbott (U.S.) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 66. Abbott (U.S.) Recent Development
Table 67. AstraZeneca (Europe) Company Details
Table 68. AstraZeneca (Europe) Business Overview
Table 69. AstraZeneca (Europe) Influenza Vaccination Product
Table 70. AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca (Europe) Recent Development
Table 72. BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
Table 73. BioCryst Pharmaceuticals, Inc. (U.S.) Business Overview
Table 74. BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Product
Table 75. BioCryst Pharmaceuticals, Inc. (U.S.) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 76. BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
Table 77. Novartis AG (Europe) Company Details
Table 78. Novartis AG (Europe) Business Overview
Table 79. Novartis AG (Europe) Influenza Vaccination Product
Table 80. Novartis AG (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 81. Novartis AG (Europe) Recent Development
Table 82. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
Table 83. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Business Overview
Table 84. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Product
Table 85. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 86. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
Table 87. GlaxoSmithKline plc. (Europe) Company Details
Table 88. GlaxoSmithKline plc. (Europe) Business Overview
Table 89. GlaxoSmithKline plc. (Europe) Influenza Vaccination Product
Table 90. GlaxoSmithKline plc. (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline plc. (Europe) Recent Development
Table 92. Hualan Biological Engineering Inc (Asia Pacific) Company Details
Table 93. Hualan Biological Engineering Inc (Asia Pacific) Business Overview
Table 94. Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Product
Table 95. Hualan Biological Engineering Inc (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 96. Hualan Biological Engineering Inc (Asia Pacific) Recent Development
Table 97. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
Table 98. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Business Overview
Table 99. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 100. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
Table 101. F. Hoffmann-La Roche Ltd (Europe) Company Details
Table 102. F. Hoffmann-La Roche Ltd (Europe) Business Overview
Table 103. F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Product
Table 104. F. Hoffmann-La Roche Ltd (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 105. F. Hoffmann-La Roche Ltd (Europe) Recent Development
Table 106. Sanofi (Europe) Company Details
Table 107. Sanofi (Europe) Business Overview
Table 108. Sanofi (Europe) Influenza Vaccination Product
Table 109. Sanofi (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
Table 110. Sanofi (Europe) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Vaccination Market Share by Type: 2020 VS 2027
Figure 2. Egg Based Features
Figure 3. Cell Culture Features
Figure 4. Recombinant Features
Figure 5. Global Influenza Vaccination Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Research Organizations Case Studies
Figure 8. Influenza Vaccination Report Years Considered
Figure 9. Global Influenza Vaccination Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Influenza Vaccination Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Influenza Vaccination Market Share by Regions: 2020 VS 2027
Figure 12. Global Influenza Vaccination Market Share by Regions (2022-2027)
Figure 13. Global Influenza Vaccination Market Share by Players in 2020
Figure 14. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccination as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Influenza Vaccination Revenue in 2020
Figure 16. Global Influenza Vaccination Revenue Market Share by Type (2016-2021)
Figure 17. Global Influenza Vaccination Revenue Market Share by Type (2022-2027)
Figure 18. North America Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Influenza Vaccination Market Share by Type (2016-2027)
Figure 20. North America Influenza Vaccination Market Share by Application (2016-2027)
Figure 21. North America Influenza Vaccination Market Share by Country (2016-2027)
Figure 22. United States Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Influenza Vaccination Market Share by Type (2016-2027)
Figure 26. Europe Influenza Vaccination Market Share by Application (2016-2027)
Figure 27. Europe Influenza Vaccination Market Share by Country (2016-2027)
Figure 28. Germany Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Influenza Vaccination Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Influenza Vaccination Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Influenza Vaccination Market Share by Region (2016-2027)
Figure 38. China Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Influenza Vaccination Market Share by Type (2016-2027)
Figure 46. Latin America Influenza Vaccination Market Share by Application (2016-2027)
Figure 47. Latin America Influenza Vaccination Market Share by Country (2016-2027)
Figure 48. Mexico Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Influenza Vaccination Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Influenza Vaccination Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Influenza Vaccination Market Share by Country (2016-2027)
Figure 54. Turkey Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 58. AstraZeneca (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 59. BioCryst Pharmaceuticals, Inc. (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 60. Novartis AG (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 61. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 62. GlaxoSmithKline plc. (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 63. Hualan Biological Engineering Inc (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 64. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 65. F. Hoffmann-La Roche Ltd (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 66. Sanofi (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---